Pure Bioscience PURE
OTC PURE
$0.07 -0.01 (-12.50%)
At close: Oct 19, 2026 · 4:00 PM EDT

Pure Bioscience (PURE) Current Deferred Revenue (2012)

Updated

Pure Bioscience (PURE) reported Current Deferred Revenue of $66,000 for fiscal Q4 2012 (quarter ended Jul 31, 2012).

Analysis

Pure Bioscience (PURE) Current Deferred Revenue (2012) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Linde 232.21 Bn 213.79 Bn 4.43 Bn
2 Corning 116.71 Bn 109.28 Bn 1.63 Bn
3 Sherwin Williams 82.35 Bn 81.39 Bn 3.34 Bn
4 Air Products & Chemicals 67.59 Bn 62.77 Bn 1.04 Bn
5 LyondellBasell Industries 40.70 Bn 30.21 Bn 2.04 Bn
6 Nutrien 32.93 Bn 29.76 Bn 3.25 Bn
7 Qnity Electronics 25.51 Bn 22.64 Bn 666.00 Mn
8 Ati 25.03 Bn 23.05 Bn 309.80 Mn
9 Ppg Industries 24.52 Bn 17.18 Bn 1.81 Bn
10 Pure Bioscience 9.10 Mn 7.15 Mn 269,000.00
Historic Data

Historic Data

Download Data
DateValue
Jul 31, 2012 66,000.00
API Access

Pure Bioscience Current Deferred Revenue API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=current-deferred-revenue&ticker=PURE&period=max&api_key=YOUR_API_KEY